Trans-Cinnamaldehyde Composition for Drug-Resistant Infections

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a growing need for novel anti-microbial agents effective against drug-resistant bacteria, fungi, and viruses, as existing compounds face issues with resistance, side effects, and limited spectrum of activity, particularly against Gram-negative bacteria and fungi.

Innovation Solution

A composition comprising a synergistic blend of trans-cinnamaldehyde and a potentiating agent, including terpenoids and phenylpropane derivatives, which enhances antimicrobial activity while reducing toxicity and resistance induction, offering broad-spectrum efficacy against drug-resistant microbes, including bacteria, fungi, and viruses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing anti-microbial compounds are used, then antimicrobial activity is achieved, but drug resistance develops and spectrum of activity is limited

Engineering Contradiction:
Improveantimicrobial activityVSAvoidspectrum of activity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines trans-cinnamaldehyde with potentiating agents (terpenoids and phenylpropane derivatives) to create a synergistic composition. This merging of multiple compounds addresses the limitation of single-agent therapy by broadening the spectrum of activity while maintaining reliable antimicrobial effects against resistant pathogens.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention uses a composite formulation comprising trans-cinnamaldehyde in combination with terpenoids and phenylpropane derivatives. This composite approach enables the composition to overcome drug resistance and expand activity spectrum beyond what individual compounds can achieve alone.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If trans-cinnamaldehyde is used alone, then broad-spectrum antimicrobial activity is achieved, but toxicity increases

Engineering Contradiction:
Improvebroad-spectrum activityVSAvoidtoxicity
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the composition parameters by combining trans-cinnamaldehyde with specific potentiating agents in optimized ratios. This parameter change allows the formulation to maintain broad-spectrum activity while reducing the toxic effects associated with using trans-cinnamaldehyde alone at high concentrations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The potentiating agents (terpenoids and phenylpropane derivatives) act as intermediaries that enhance the antimicrobial efficacy of trans-cinnamaldehyde, allowing lower doses of the active compound to be used while maintaining broad-spectrum activity and reducing toxicity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If classical anti-bacterial analogs are used, then initial antimicrobial effect is achieved, but resistance develops rapidly

Engineering Contradiction:
Improveantimicrobial effectVSAvoidresistance development time
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The composition employs trans-cinnamaldehyde combined with potentiating agents that work together to prevent resistance development before it occurs. The synergistic interaction creates a preliminary defensive mechanism that counters resistance mechanisms, extending the duration of effective antimicrobial action.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The multi-component composition provides multi-functionality by simultaneously targeting multiple bacterial pathways and mechanisms. This universal approach prevents rapid resistance development by making it difficult for pathogens to develop single-point resistance mutations.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20230049807A1Pharmaceutical composition comprising trans - cinnamaldehyde and its use in the treatment of infections
Publication Date: 2023.02.16 SEPTEOS
  • US20230049807A1 patent drawing
  • US20230049807A1 patent drawing
  • US20230049807A1 patent drawing

AI summary

This invention pertains to an anti-microbial, in particular anti-bacterial, more particularly against Gram negative bacteria, and/or anti-fungal composition comprising as active blend trans-cinnamaldehyde and a potentiating agent. In particular this composition is intended for preventing and/or treating microbial infection in an animal.